CLS (LON:CLI) Earns Buy Rating from Liberum Capital

Liberum Capital reaffirmed their buy rating on shares of CLS (LON:CLI) in a research note released on Wednesday, ThisIsMoney.Co.Uk reports.

Other equities analysts also recently issued research reports about the stock. Peel Hunt reaffirmed a buy rating on shares of CLS in a research note on Friday, August 9th. Berenberg Bank reaffirmed a buy rating on shares of CLS in a research note on Friday, June 14th.

LON:CLI opened at GBX 224.50 ($2.93) on Wednesday. The company has a quick ratio of 1.05, a current ratio of 2.18 and a debt-to-equity ratio of 82.33. The company has a market cap of $914.60 million and a P/E ratio of 6.97. CLS has a fifty-two week low of GBX 195 ($2.55) and a fifty-two week high of GBX 257 ($3.36). The firm’s 50 day moving average is GBX 225.18 and its two-hundred day moving average is GBX 233.14.

The business also recently declared a dividend, which will be paid on Friday, September 27th. Shareholders of record on Thursday, August 22nd will be paid a dividend of GBX 2.35 ($0.03) per share. This represents a yield of 1.03%. The ex-dividend date is Thursday, August 22nd. CLS’s dividend payout ratio is currently 0.22%.

In related news, insider Andrew Kirkman purchased 20,000 shares of the business’s stock in a transaction on Wednesday, August 14th. The shares were bought at an average price of GBX 228 ($2.98) per share, with a total value of £45,600 ($59,584.48). In the last ninety days, insiders have acquired 70,133 shares of company stock worth $15,589,954.

About CLS

CLS Holdings plc, together with its subsidiaries, engages in the investment, development, and management of commercial properties in the United Kingdom, France, Germany, and France. It operates in two segments, Investment Property and Other Investments. The company also invests a hotel; and corporate bonds, shares, and other corporate investments.

Featured Article: How to Profit and Limit Losses With Stop Orders

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.